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Abstract 
Background: PubChem is an open archive consisting of a set of three primary public databases (BioAssay, Com-
pound, and Substance). It contains information on a broad range of chemical entities, including small molecules, 
lipids, carbohydrates, and (chemically modified) amino acid and nucleic acid sequences (including siRNA and miRNA). 
Currently (as of Nov. 2015), PubChem contains more than 150 million depositor-provided chemical substance descrip-
tions, 60 million unique chemical structures, and 225 million biological activity test results provided from over 1 mil-
lion biological assay records.
Description: Many PubChem records (substances, compounds, and assays) include depositor-provided cross-refer-
ences to scientific articles in PubMed. Some PubChem contributors provide bioactivity data extracted from scientific 
articles. Literature-derived bioactivity data complement high-throughput screening (HTS) data from the concluded 
NIH Molecular Libraries Program and other HTS projects. Some journals provide PubChem with information on chemi-
cals that appear in their newly published articles, enabling concurrent publication of scientific articles in journals and 
associated data in public databases. In addition, PubChem links records to PubMed articles indexed with the Medical 
Subject Heading (MeSH) controlled vocabulary thesaurus.
Conclusion: Literature information, both provided by depositors and derived from MeSH annotations, can be 
accessed using PubChem’s web interfaces, enabling users to explore information available in literature related to 
PubChem records beyond typical web search results.
© 2016 US Government. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
PubChem (https://pubchem.ncbi.nlm.nih.gov) [1–6] is 
an open archive which contains information on a broad 
range of chemical entities, including small molecules, 
lipids, carbohydrates, and (chemically modified) amino 
acid and nucleic acid sequences (including siRNA and 
miRNA). Since it was launched in 2004 as a component 
of the Molecular Libraries Program (MLP) of the U.S. 
National Institutes of Health (NIH), PubChem has been 
serving as a chemical information resource for scientific 
communities in many areas including chemical biology, 
cheminformatics, and medicinal chemistry.
Data organization in PubChem is described in detail 
elsewhere [6, 7], and only a brief summary is given here. 
Chemical information contained in PubChem is depos-
ited by more than 350 data contributors including gov-
ernment agencies, academic institutions, pharmaceutical 
companies, chemical vendors, and publishers. PubChem 
organizes this information into three primary databases: 
Substance, Compound, and BioAssay. The Substance 
database (https://www.ncbi.nlm.nih.gov/pcsubstance) 
archives depositor-provided chemical substance descrip-
tions. The Compound database (https://www.ncbi.nlm.
nih.gov/pccompound) stores unique chemical struc-
tures extracted from the Substance database through a 
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standardization process. The BioAssay database (https://
www.ncbi.nlm.nih.gov/pcassay) contains descriptions 
and results of biological assay experiments. The record 
accessions used for the respective PubChem databases 
are the Substance ID (SID), Compound ID (CID) and 
Assay ID (AID).
As of November 2015, PubChem contains more than 
150  million depositor-provided substance descriptions, 
60  million unique chemical structures, and 225  million 
biological activity test results (from over 1 million assay 
experiments performed on more than 2  million small-
molecules covering almost 10,000 unique protein target 
sequences that correspond to more than 5000 genes). It 
also contains RNA interference (RNAi) screening assays 
that target over 15,000 genes. Many of these PubChem 
records (substances, compounds, and assays) have depos-
itor-provided cross-references to scientific articles in 
PubMed (https://www.pubmed.gov) [8–11], a biomedical 
literature search system developed and maintained by the 
National Center for Biotechnology Information (NCBI) 
at the National Library of Medicine (NLM), an institute 
within NIH.
PubMed, whose primary identifier is the PubMed ID 
(PMID), provides free access to more than 25  million 
scientific abstracts covering the fields of medicine, nurs-
ing, dentistry, veterinary medicine, health care systems, 
and preclinical sciences. Nearly 90 % of the PubMed con-
tents are from MEDLINE [11, 12], which is the NLM’s 
bibliographic database containing more than 22  million 
abstracts of journal articles in life sciences with a concen-
tration in biomedicine. A distinctive feature of MEDLINE 
is that the records are “indexed” with Medical Subject 
Headings (MeSH) [13, 14]. MeSH is the NLM’s con-
trolled vocabulary thesaurus, consisting of sets of terms 
naming descriptors in a hierarchical structure. Indexing 
of scientific papers with MeSH terms enables users to 
perform a literature search at various levels of specific-
ity. Of keen interest to PubChem is that MeSH includes 
a large number of chemical substance concepts, chemical 
names associated with each concept, and specific/quali-
fied links between these concepts and PMIDs. Consid-
ering PubChem contains many chemical names, MeSH 
allows PubChem records to be linked to the biomedical 
literature using matching chemical names.
There are multiple sources of links to PubMed articles 
within PubChem and different contexts where they can 
be specified within a given PubChem record type. Under-
standing where these links can be provided and who pro-
vides them can help aid in their use. For example, they 
can provide PubChem users quick access to the original 
source article of a bioactivity result. In some cases, data 
contributors provide chemical information extracted 
from the scientific literature through manual curation or 
data mining. In addition, PubChem performs an auto-
mated process that annotates PubChem records with 
MeSH terms (by means of chemical name matching), 
creating associations between PubChem records and 
PubMed articles that share the same MeSH annotation. 
This work summarizes the various sources of PubMed 
links in PubChem, explains ways to access these links, 
and examines the scope of literature information associ-
ated with PubChem records.
Construction and content
Depositor‑provided cross‑references to scientific articles
Cross‑references from substances/compounds to PubMed 
articles
Table  1 summarizes the number of depositor-provided 
cross-references (links) from PubChem substances and 
compounds to PubMed articles (NSID-PMID and NCID-
PMID, respectively) as well as the associated number of 
substances, compounds, and PubMed article records 
(NSID, NCID, and NPMID, respectively). As of November 
2015, PubChem has more than five million depositor-
provided cross-references (NSID-PMID  =  5,614,567) from 
300 thousand substances (NSID = 301,358) to two million 
PubMed articles (NPMID  =  2,192,601). Cross-references 
from compounds to PubMed articles are derived from 
corresponding substances. Given that compounds are the 
unique chemical structures extracted from the Substance 
database (and there can be many substance records for 
the same chemical), one cross-reference from a com-
pound to a PubMed article is counted if one (or more) 
of the compound’s corresponding substances contains a 
cross-reference to that given PubMed article. Therefore, 
the count of compounds with PubMed cross-references 
is less than the count of substances with cross-references 
(NCID = 261,497 vs. NSID = 301,358). Similarly, the count 
of CID-PMID cross-references is less than the count of 
SID-PMID cross-references (NCID-PMID  =  5,412,256 vs. 
NSID-PMID = 5,614,567).
The biggest source of SID-PMID cross-references is the 
IBM Almaden Research Center (http://www.research.ibm.
com/labs/almaden/index.shtml). This PubChem depositor 
provides PMIDs of the scientific articles mentioning 
a particular chemical. While beyond the scope of this 
paper, they also provide links to patent documents 
mentioning a particular chemical. The IBM substance 
records provide more than 90 % of the SID-PMID cross-
references involving about half of all substance records 
containing cross-references to PubMed articles.
The next largest sources of depositor-provided lit-
erature links for PubChem Substance and Compound 
records are ChemDB [http://chemdb.niaid.nih.gov/—
provided by the U.S. National Institute of Allergy and 
Infectious Diseases (NIAID)] and the Comparative 
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Toxicogenomics Database (CTD) (http://ctdbase.org/) 
[15], which provide 144 thousand cross-references for 
114 thousand substances and 226 thousand cross-refer-
ences for 14 thousand substances, respectively. Other 
notable contributors for biologically relevant SID-PMID 
cross-references include IUPHAR/BPS Guide to Phar-
macology (http://www.guidetopharmacology.org) [16], 
Human Metabolome Database (HMDB) (http://www.
hmdb.ca/) [17], Immune Epitope Database (IEDB) 
(http://www.iedb.org/) [18], BioCyc (http://biocyc.org/) 
[19], DrugBank (http://www.drugbank.ca/) [20], and 
the Biocatalysis/Biodegradation database (BBD) (http://
eawag-bbd.ethz.ch/) [21].
The disproportionate number of cross-references and 
chemical substance coverage coming from a handful of 
data contributors (Table 1) points to their diverging focus 
areas in data collection. For example, IBM uses data min-
ing to collect information on patents and scientific papers 
that mention a very broad range of chemicals, resulting 
in a large number of links to scientific papers. On the 
other hand, DrugBank primarily focuses on U.S. Food 
and Drug Administration (FDA) drugs (approved and 
experimental) and collects relevant information through 
manual curation. Similarly, the IEDB resource performs 
manual curation but considers chemical substances in 
the immunology epitope research domain. As such, 
PMID cross-references provided by different chemical 
substance data depositors can have a significantly varied 
focus and approach.
Bioactivity data extracted from scientific articles
Data contributors may supply PubChem with a list of 
PMIDs for scientific articles that have information rel-
evant to a given assay record. These articles may pro-
vide various kinds of information related to the assay, 
such as assay detection method, experimental protocols, 
assay targets, diseases associated with the targets, known 
ligands that bind to the targets, and so on. These articles 
may or may not be relevant to substances and compounds 
tested in those assays. With that said, it is of particular 
interest that some PubChem contributors provide bioac-
tivity information extracted from the literature through 
the means of manual curation or data mining. These 
data are an important source of bioactivity information 
in PubChem that complements high-throughput screen-
ing (HTS) data from the now-concluded NIH Molecular 
Table 1 Summary of depositor-provided cross-references to PubMed articles from PubChem substances and compounds
NSID and NCID are the number of PubChem substances and compounds with depositor-provided cross-references to PubMed articles, respectively, and NSID-PMID and 
NCID-PMID are the number of depositor-provided cross-references from PubChem substance and compound records to PubMed articles, respectively. NPMID is the 
number of unique PubMed articles associated with the PubChem records via the depositor-provided cross-references
a http://www.research.ibm.com/labs/almaden/index.shtml
b Ref. [15]. http://ctdbase.org
c http://chemdb.niaid.nih.gov
d Ref. [16]. http://www.guidetopharmacology.org
e Ref. [17]. http://www.hmdb.ca
f Ref. [18]. http://www.iedb.org
g Ref. [19]. http://biocyc.org
h Ref. [20]. http://www.drugbank.ca
i Ref. [21]. http://eawag-bbd.ethz.ch
j  http://bidd.nus.edu.sg
Number of cross‑references Number of records involved
NSID-PMID NCID-PMID NPMID NSID NCID
All 5,614,567 5,412,256 2,192,601 301,358 261,497
IBM Almaden Research Centera 5,196,617 5,125,878 2,107,354 152,777 147,576
Comparative toxicogenomics databaseb 226,585 111,029 110,000 14,463 7856
NIAID ChemDBc 144,477 133,012 11,951 114,953 104,418
IUPHAR/BPS guide to PHARMACOLOGYd 14,309 11,250 7163 6398 4913
Human metabolome databasee 13,998 13,971 10,414 1788 1781
Immune epitope database (IEDB)f 4849 3863 1747 2067 1948
BioCycg 3318 3267 1386 2989 2939
DrugBankh 3249 3225 3158 1044 1030
Biocatalysis/biodegradation database (BBD)i 2299 2299 644 1343 1342
Bioinformatics and drug design (BIDD) groupj 2270 2262 91 1768 1673
Others 2596 2200 1180 1768 1448
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Libraries Program. Table 2 shows major contributors that 
provide literature-extracted bioactivity data.
ChEMBL (https://www.ebi.ac.uk/chembl/) [22] is 
a public database of bioactivity information for com-
pounds. Most of the bioactivity data contained in 
ChEMBL is manually extracted from the full text of 
peer-reviewed scientific papers published in about 50 
journals in the medicinal chemistry and natural prod-
uct domains. From each paper, detailed information 
is extracted on the compounds tested, the assays per-
formed, and the targets for the assays. Often multi-
ple data sets are generated for a single paper, resulting 
in multiple BioAssay records for that publication. The 
ChEMBL data is updated on a regular basis, with peri-
odic releases approximately every 3–6 months. The cur-
rent version of ChEMBL (ChEMBL v20, as of September 
2015) contains 13  million bioactivities for 1.5  million 
unique compounds, abstracted from about 60 thousand 
publications or provided by other data sources. ChEMBL 
contributes its literature-derived data to the PubChem 
BioAssay database.
The Guide to Pharmacology (http://www.guidetop-
harmacology.org) [16], created under the auspices of the 
International Union of Basic and Clinical Pharmacol-
ogy (IUPHAR) and the British Pharmacological Society 
(BPS), provides in-depth integrated views of the phar-
macology, genetics, functions, and pathophysiology of 
important drug targets, including G-protein-coupled 
receptors (GPCRs), ion channels, and nuclear hormone 
receptors (NHRs). In addition, it provides information on 
the interactions between these target proteins and their 
ligands. PubMed citations containing the bioactivity data 
for these ligands are also provided to PubChem.
The PDBbind database (http://www.pdbbind-cn.org) 
[23] collects experimentally measured binding affin-
ity data (IC50, Kd, or Ki) for biomolecular complexes in 
the Protein Data Bank (PDB) [24]. The majority of the 
data in PDBbind is for complexes between proteins and 
small molecule ligands, although it also contains other 
types of complexes such as protein–protein, protein–
nucleic acid, and nucleic acid–ligand complexes. All 
binding affinity data in PDBbind are manually curated 
from nearly 24,000 original references. PDBbind con-
tributes to PubChem binding affinity data for ~10,000 
protein–ligand complexes that involve ~3000 unique 
small molecule chemical structures, with related infor-
mation including the PMID for the source article, PDB 
ID and MMDB ID [25] for the protein–ligand struc-
tures, and the protein GI and name for the protein 
target.
BindingDB (https://www.bindingdb.org) [26] provides 
measured binding affinities, focusing chiefly on the inter-
actions of proteins considered to be drug targets with 
small, drug-like molecules. BindingDB contains more 
than one million binding interactions for seven thousand 
protein targets and 495 thousand small molecules.
GLIDA (GPCR-Ligand Database) (http://pharminfo.
pharm.kyoto-u.ac.jp/services/glida/) [27] is a public 
chemical genomics database that provides information 
on GPCRs, their ligands, and interactions between them. 
The ligand-binding information was manually collected 
and curated from PubMed and other sources. Although 
GLIDA has ceased updates since 2010, it is still opera-
tional and its data are fully accessible.
In addition to these resources containing manually 
curated sources of bioactivity, there is a growing num-
ber of AID-PMID references deposited directly by the 
authors of scientific publications uploading their research 
data into the PubChem BioAssay database. This includes 
researchers from RNAi screening and is open to all 
researchers in the chemical biology, medicinal chemis-
try, and related fields. Such submissions help to satisfy 
Table 2 Summary of cross-references from literature-extracted bioassay data to PubMed articles
NAID, NSID and NCID are the number of PubChem assays, substances and compounds extracted from scientific articles, respectively; and NAID-PMID, NSID-PMID and NCID-PMID 
are the number of cross-references from PubChem assays, substances, and compounds to PubMed articles, respectively. NPMID is the number of unique PubMed 
articles from which the assay data are extracted
a Ref. [22]. https://www.ebi.ac.uk/chembl/
b Ref. [23]. http://www.pdbbind-cn.org
c Ref. [16]. http://www.guidetopharmacology.org
d Ref. [26]. https://www.bindingdb.org
e Ref. [27]. http://pharminfo.pharm.kyoto-u.ac.jp/services/glida/
Source NAID-PMID NSID-PMID NCID-PMID NPMID NAID NSID NCID
ChEMBLa 829,503 1,068,347 1,058,637 55,582 828,594 860,191 849,149
PDBbindb 6946 20,221 16,993 5252 4 10,543 8158
IUPHAR/BPS guide to pharmacologyc 442 1088 1080 151 55 273 264
BindingDBd 143 3114 3113 121 19 3101 3098
GLIDAe – – – – 6 19,474 19,458
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open access and data sharing requirements from research 
funding agencies.
Note that different PubChem BioAssay data sources 
can provide PubMed links in different ways. For exam-
ple, ChEMBL provides the cross-reference between an 
assay and the article from which bioactivity information 
for that assay were extracted, and therefore, literature 
evidence on bioactivity data for substances tested in that 
assay can be deduced from the AID-PMID cross-refer-
ence. PDBbind provides information on the source article 
of bioactivity data for each substance tested in an assay 
(as a property of the tested substance reported in the 
assay data table). GLIDA does not explicitly provide liter-
ature information for assays or tested substances in them. 
Instead, it provides the GLIDA ID (the database identifier 
used in GLIDA) for a substance. This external ID is used 
to search for the corresponding record in GLIDA to get 
information on the source article.
Chemical information provided by journal publishers
Publishers are also an indirect source of records in 
PubChem. While many funding agencies mandate that 
data from studies they support should be freely available 
to the public, some journals also require data submission 
of research data to public databases as a precondition to 
publishing a research paper. Data sharing requirements 
by journals and granting agencies may be satisfied by use 
of the PubChem data archiving platform.
Some journals directly provide PubChem with litera-
ture information for chemicals. Examples include jour-
nals published by the Nature Publishing Group (including 
Nature Chemical Biology, Nature Chemistry, and Nature 
Communications). When a new article is published in 
one of these journals, the publisher identifies chemicals 
studied in the article and submits them to PubChem with 
information on the source article (including the journal 
name, authors, title, publication date, and digital object 
identifier (DOI)). These chemicals are stored in the Sub-
stance database, and the substance record page for each 
chemical has a link to the source article (see Fig. 1). Simi-
larly, on the web page of the original article the publisher 
provides links to the corresponding substance records 
in PubChem. This allows readers to readily access com-
prehensive information available in PubChem for these 
chemicals, through the compound records  associated 
with the substance records. This demonstrates the ben-
efit of concurrent publication of scientific articles in jour-
nals and associated data in public databases.
Automated annotations of PubChem records with PubMed 
articles via MeSH
PubChem generates CID-PMID associations via MeSH 
using depositor-provided chemical names. This is 
achieved by first determining which depositor-provided 
chemical names in PubChem are also found in MeSH. 
Not all chemical names in PubChem are used in this 
step. Chemical names provided to PubChem are passed 
through a sort-of crowd-sourcing filtering process, where 
consistency of chemical name-structure associations of 
depositor-provided synonyms is determined using differ-
ing levels of chemical structure sameness (e.g., potentially 
grouping different charge states or salt forms of the same 
chemical). This reduces the count of PubChem Com-
pound records associated with a given chemical name. 
The resulting filtered chemical names are considered “fil-
tered synonyms” in PubChem.
Once PubChem chemical names are matched to MeSH 
concepts, the MeSH concept is associated with the 
PubChem Compound record containing matching chemi-
cal names. Additional consistency filtering suppresses mul-
tiple MeSH concepts from being associated with the same 
PubChem Compound record (by taking the consensus 
MeSH concept for a given compound record). This helps to 
reduce errors but also helps to provide a consistent chemi-
cal representation for a given MeSH chemical concept.
The CID-PMID associations are generated in a final 
step. PubMed records that are annotated with a given 
MeSH chemical concept are then associated with the 
PubChem Compound record linked to the MeSH chemi-
cal concept. In this way (CID→Name→MeSH→PMID), 
linking between PubChem and PubMed is achieved.
The MeSH annotations of PubChem records are 
“indexed” as indices for text search within NCBI’s Entrez 
search system [1, 28, 29]. Entrez is the text/numeric 
search and retrieval system that integrates PubChem’s 
three primary databases (BioAssay, Compound, and Sub-
stance) with approximately forty other NCBI databases, 
including PubMed and MeSH. The Entrez indices are tied 
to individual records in PubChem and include informa-
tion on particular aspects (often referred to as fields) of 
the records. The available fields and their indexed terms 
in PubChem can be explored on the Advanced Search 
page as part of the Search Builder (see Fig. 2).
The Entrez indices derived from MeSH annotations 
are summarized in Table 3. The “Complete MeSH Term” 
Entrez index retrieves compounds annotated with the 
MeSH term that exactly matches the query, while the 
“MeSH Term” index searches for those with the MeSH 
terms that partially match the query. The “MeSH Tree 
Node” index finds compounds annotated with the query 
MeSH term and those with any MeSH terms that cor-
respond to the child nodes beneath the node for the 
query term. The “MeSH Description” index searches the 
descriptions of MeSH terms for the query string.
Some MeSH annotations (such as solvents, carcinogens, 
inhibitors, and so on) are too general to describe a specific 
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biological function of a compound. Therefore, “Pharma-
cological Actions” (a subset of MeSH terms) are separately 
included as an Entrez index, as these annotations indicate 
specific biological roles of chemical concepts. The “Phar-
macological Action ID” index searches for records with 
the Pharmacological Action annotation corresponding to 
a numeric identifier assigned by MeSH given as a query.
MeSH annotations of a compound can be used to anno-
tate substance records corresponding to that compound. 
PubChem annotates substance records with MeSH terms 
for Entrez searching purposes similar to compound 
records. However, no attempt is made to filter chemical 
names or MeSH concepts for substance records, using 
chemical name information directly provided by individ-
ual data contributors for a given substance. In addition, 
the MeSH annotations of substances are not displayed on 
the substance record page, to avoid confusion about the 
provenance of displayed information.
Fig. 1 The substance record page for SID 85856310 (warfarin), with a link to the source article published in Nature Chemical Biology. The original 
article has a link to SID 85856310 in PubChem, allowing article readers to access comprehensive information on warfarin available in the PubChem 
Compound database, by clicking a link to the Compound Summary page for CID 54678486
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MeSH annotations to compound records made by 
PubChem are used to annotate assay records testing 
the compounds. They are also used to generate Entrez 
indices that allow one to search the PubChem BioAssay 
database for assays that have tested compounds with a 
particular MeSH annotation. For example, the “MeSH 
Term Tested” index retrieves assay records in which any 
tested compound is annotated with the query MeSH 
term. The “MeSH Term Active” retrieves assays in which 
only active compounds are annotated with the query 
MeSH term.
Utility and discussion
Entrez links from PubChem records to PubMed articles
The associations between PubChem records and Pub-
Med records, whether provided by data contributors or 
computationally derived via common MeSH annotations, 
are available to PubChem users as Entrez links. In gen-
eral, Entrez links are crosslinks between records in differ-
ent Entrez databases or within the same Entrez database. 
The Entrez links provide a way to discover relevant infor-
mation in Entrez databases based on a user’s specific 
interests. For example, one can readily obtain a list of 
Fig. 2 Retrieving compound records annotated with MeSH terms using the Advanced Search Builder. Clicking the “Advanced” link under the “Com-
pound” tab on the PubChem Homepage directs users to the PubChem Compound Advanced Search Builder. Selecting the “MeSHTerm” from the 
dropdown menu and providing a MeSH term in the search box will retrieve compounds annotated with that MeSH term
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scientific articles related to a particular molecule through 
an Entrez link from the corresponding compound record 
in PubChem to associated articles in PubMed. As another 
example, users may access all data sets (AID) in the Bio-
Assay database associated with a research article in Pub-
Med. Entrez links from PubChem to PubMed records are 
available to users in several ways.
Entrez links on the document summary (DocSum) page
An Entrez document summary (DocSum) page, as shown 
in Fig.  3, displays multiple records returned from an 
Entrez search. Entrez links are available via the “Find 
related data” menu on the right column. If no compounds 
are selected, these links will be applied to the entire 
search result list by default. Note that, when “PubMed” 
is selected from the Database drop-down menu, three 
items appear under the “Option” menu: “PubMed Cita-
tions”, “PubMed (MeSH Keyword)”, and “PubMed (Pub-
lisher)”. These options correspond to different types of 
Compound-to-PubMed Entrez Links.
The first option “PubMed Citations” is for Entrez links 
derived from cross-references to PubMed articles that 
data contributors provided to PubChem. That is, this 
option will retrieve scientific articles containing informa-
tion relevant to a given chemical, according to PubChem 
depositors. On the other hand, the third option, “PubMed 
(Publisher)”, is from CID-PMID associations provided by 
journal publishers to PubMed (not PubChem) as a part 
of PubMed abstract submission. Both the first and third 
options are similar in the sense that some organization 
(e.g., data contributors or journal publishers) contributed 
the chemical-literature associations. However, the sec-
ond option “PubMed (MeSH Keyword)” corresponds to 
CID-PMID associations derived via MeSH annotations. 
This option returns articles annotated by Medline index-
ers with MeSH terms (chemical names). MeSH annota-
tion can be further leveraged to find which articles have a 
given MeSH term as a major topic to obtain articles spe-
cifically about that chemical.
Three different types of Entrez Links also exist for sub-
stance records to PubMed articles, similar to the Com-
pound-to-PubMed links. For the BioAssay-to-PubMed 
links, only one type of Entrez link to PubMed is avail-
able through the right column of the DocSum page. 
This returns publications associated with the BioAssay 
records, based on AID-PMID associations provided by 
data contributors to PubChem. These publications may 
be either source articles from which assay data are col-
lected in curation projects, or general articles that pro-
vide background information relevant to the assay.
Entrez links on the Compound Summary page
The Compound Summary page of a compound provides 
an aggregated view of all available information on that 
compound collected from various data sources (Fig.  4). 
When a compound has literature information, this will 
be shown in the Literature section. A link to PubMed 
articles associated with the compound via depositor-pro-
vided cross-references is displayed under the Depositor 
Provided PubMed Citations section, and a link to those 
Table 3 Entrez indices used to search for records with MeSH annotations
Entrez index Description
Compound database
 Complete MeSH term Retrieve compounds annotated with the MeSH term that exactly matches the query
 MESH term Retrieve compounds annotated with MeSH terms that partially match the query. Note that MeSH entry terms (synonyms for 
the Medical Subject Heading term) are also indexed
 MeSH tree node Retrieve compounds annotated with the MeSH term that match the query and those annotated with any MeSH terms 
beneath the node corresponding to that MeSH term. For example, “Penicillins[MeSHTreeNode]” will retrieve records anno-
tated with MeSH term “Penicillins”and those with MeSH terms “Oxacillin”, “Cloxacillin”, and so on, which correspond to child 
nodes beneath the “Penicillins” node in the MeSH tree
 MeSH description Retrieve compounds annotated with the MeSH terms whose description contains the query string
 PharmAction Retrieve compounds annotated with the Pharmacological Action term, which are a subset of MeSH terms
 PharmActionID Retrieve compounds annotated with the Pharmacological Action term corresponding to the numeric identifier given as a 
query
BioAssay database
 MeSH term active Retrieve assays in which only an active substance is annotated with the MeSH term given as a query
 MeSH term tested Retrieve assays in which any tested substance is annotated with the MeSH term given as a query
 MeSH description active Retrieve assays in which only an active substance is annotated with the MeSH terms whose descriptions have a query string
 MeSH description tested Retrieve assays in which any tested substance is annotated with the MeSH terms whose descriptions have a query string
 Pharm action active Retrieve assays in which only an active substance has the Pharmacological Action annotation given as a query
 Pharm action tested Retrieve assays in which any tested substance has the Pharmacological Action annotation given as a query
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associated with the compound via common MeSH anno-
tations is shown under the NLM Curated PubMed Cita-
tions section. In some cases, the per compound PMID 
associations derived via MeSH annotations are catego-
rized according to MeSH subheadings, which allow for 
describing particular aspects of a subject. MeSH terms 
associated with a compound are displayed under the 
Classification section.
Entrez filters from PubChem records to PubMed articles
One may want to retrieve all PubChem records associ-
ated with PubMed articles. This can be done using Entrez 
filters, which indicate whether or not a given record in an 
Entrez database has a particular type of annotations. The 
Entrez filters may be used to subset other Entrez searches 
according to this annotation type, by adding the filter to 
the query string. Importantly, Entrez filters are closely 
Fig. 3 The document summary (DocSum) page that shows the results for a search for “warfarin”. Scientific articles associated with the returned 
compound records can be accessed via the Entrez Links, which are available under the “Find related data” menu (for multiple records) or from a link 
for individual compound records
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related to Entrez links in that many Entrez filters are gen-
erated by checking whether a given record in an Entrez 
database has an Entrez link to a record in the same or dif-
ferent Entrez database. The filters for each Entrez data-
base may be listed by going to the advanced search page 
of each database, selecting “Filter” from the “All Fields” 
dropdown, and clicking “Show index list” (Fig. 5).
Table  4 lists the Entrez Filters available in PubChem 
that can be used to get the list of records associated 
with PubMed articles. As mentioned in the previous 
section, a DocSum page for a compound search result 
(Fig. 3) shows three different Entrez links between com-
pounds and PubMed articles. These three links are used 
to generate three Entrez filters that indicate the presence 
of associated PubMed articles for compound records: 
(1) pccompound_pubmed, (2) pccompound_pubmed_
mesh, and (3) pccompound_pccompound_publisher. 
The “pccompound_pubmed” filter allows one to retrieve 
compound records with cross-references provided to 
PubChem by data contributors. The “pccompound_pub-
med_publisher” filter retrieves those with cross-refer-
ences to PubMed articles that are provided to PubMed 
by publishers. The “pccompound_pubmed_mesh” filter 
retrieves those with computationally generated links to 
PubMed articles that have a common MeSH annotation, 
as explained in the previous section.
Fig. 4 The literature section of the Compound Summary page (DocSum) for CID 5288826 (morphine). Clicking the “Literature” section in the Table 
of Contents allows users to jump to the literature section, which consists of two subsections: depositor-provided and NLM-curated PubMed cita-
tions
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While the “pccompound_mesh” filter retrieves any com-
pounds with MeSH annotations, the “pccompound_mesh_
pharm” filter selects those with Pharmacological Action 
annotations. These filters are equivalent to the “has_mesh” 
and “has_pharm” filters, respectively. The “pccompound_
pmc” filter allows one to choose compounds that have 
associated full-text articles in PubMed Central.
The Substance database also has Entrez filters that 
are similar to those for compound records listed in 
Table  4. For example, the “pcsubstance_pubmed” and 
“pcsubstance_pubmed_publisher” filters can be used to 
find substance records with cross-references to PubMed 
that are provided by PubChem depositors to PubChem 
and by publishers to PubMed, respectively.
Programmatic access to literature information in PubChem
Literature information in PubChem can be program-
matically accessed through E-Utilities [30] or PUG-REST 
[31]. More detailed information on programmatic access 
to PubChem is given elsewhere [31].
Fig. 5 Retrieving compound records with a particular property using the Entrez filters. Selecting the “Filter” option under the drop-down menu on 
the PubChem Compound Advanced Search Builder allows you to retrieve compounds with a particular property or annotation. Available filters can 
be shown or hidden by clicking the “Show/Hide index list” button
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Discussion
Figure  6 shows the frequencies of PMIDs per CID and 
CIDs per PMID for the three types of CID-PMID asso-
ciations: those provided to PubChem by PubChem 
depositors (pccompound_pubmed), those derived by 
PubChem through matching between chemical names 
and MeSH terms (pccompound_pubmed_mesh), and 
those provided to PubMed by journal publishers (pccom-
pound_pubmed_publisher). Note that the frequencies 
for the pccompound_pubmed_publisher links are much 
lower than the other two link types because only a small 
number of publishers submit CID-PMID associations to 
PubMed. Therefore, this section focuses the other two 
link types.
The majority of compounds have no more than ten 
associated PMIDs (i.e., 95  % of CIDs with depositor-
provided PMIDs and 70  % of CIDs with automated 
annotations via MeSH). However, some compounds are 
associated with many PMIDs. For example, d-glucose 
has as many as 130,545 depositor-provided PMIDs and 
132,017 PMIDs generated via MeSH.
The Venn diagrams shown in Fig.  7 illustrate the 
overlap between CID-PMID associations provided by 
depositors and derived annotations via MeSH. Among 
the 39.2  million CID-PMID associations, only 4  % 
overlap, being both depositor-provided and NLM-
curated, indicating that the two types of associations 
are nearly orthogonal and complement each other. Of 
these 4  % overlapping CID-PMID pairs, the CIDs and 
PMIDs that make them up correspond to 10 and 19 % 
of all CIDs and all PMIDs found in all CID-PMID pairs, 
respectively. Importantly, although depositor-provided 
CID-PMID links are much fewer in number than those 
generated via MeSH, there are more CIDs involved in 
the depositor-provided links than in those derived via 
MeSH.
It is worth noting that the CID-PMID associations via 
MeSH tend to be limited to chemicals that are sufficiently 
well known to be included in MeSH. These chemicals 
correspond to only a small fraction of all chemicals stud-
ied in scientific articles contained in PubMed. Therefore, 
associations generated via MeSH may ignore specific 
chemicals (favoring instead a chemical class) unless they 
are already included in MeSH or sufficiently notewor-
thy to be specifically added. With that said, depositor-
provided CID-PMID associations do not suffer the same 
limitation as MeSH and provide a greatly increased num-
ber of chemicals mentioned in the biomedical literature, 
as suggested in Fig. 7.
However, a caveat against depositor-provided asso-
ciations is that the accuracy and usefulness of these 
links solely rely on individual depositors’ quality con-
trol efforts, as PubChem does not (currently) provide an 
independent quality control mechanism. To address this, 
PubChem is exploring a few possibilities. For example, 
one option is to process PubMed abstracts (and PubMed 
Central full-text papers) using text-mining software for 
chemical recognition (in text, tables, and figures). The 
resulting CID-PMID associations can be used to cross-
validate the existing depositor-provided associations and 
to better understand the context of the chemical men-
tion. Annotation of CID-PMID associations (e.g., loca-
tion, context) may help prioritize the display of PMIDs 
associated to a given compound.
Table 4 Entrez filters used to search for records with MeSH annotations
Entrez filter Description
Compound database
 has_mesh Equivalent to “pccompound_mesh”
 has_pharm Equivalent to “pccompound_mesh_pharm”
 pccompound_mesh Select compounds annotated with MeSH terms. Equivalent to “has_mesh”
 pccompound_mesh_pharm Select compounds annotated with MeSH Pharmacological Actions. Equivalent to “has_pharm”
 pccompound_pmc Select compounds that have associated full-text articles in PubMed Central
 pccompound_pubmed Select compounds that have depositor-provided cross-references to PubMed articles
 pccompound_pubmed_mesh Select compounds associated with PubMed abstracts that are annotated with common MeSH annotations
 pccompound_pubmed_publisher Select compounds that have cross-references to PubMed articles, provided to PubMed by publishers
BioAssay database
 pcassy_pmc Select assays that have associated full-text articles in PubMed Central
 pcassay_pubmed Select assays that have depositor-provided cross-references to PubMed articles
 pcassay_pubmed_major Select assays that have cross-references to the PubMed articles that contains the original bioactivity data in 
the assays
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Conclusions
Literature information available in PubChem for sub-
stances, compounds and assays, as well as how this infor-
mation can be accessed, was described. Individual data 
contributors provide PubChem with cross-references 
between chemical substances and PubMed articles 
that contain information on that substance. From these 
SID-PMID cross-references, PubChem generates cross-
references between the corresponding compound and 
the PubMed articles (i.e., CID-PMID cross-references). 
Data contributors can also supply a list of PMIDs for sci-
entific articles that have information relevant to a given 
assay record. These articles may contain various kinds of 
information related to the assay, including experimental 
protocols, assay targets, diseases associated with the tar-
gets, and known ligands that bind the targets. Of particu-
lar interest, some data contributors provide bioactivity 
data extracted from literature through manual curation 
or data mining and are an important source of bioactiv-
ity information in PubChem that complement HTS data 
from the now-concluded NIH Molecular Libraries Pro-
gram and other HTS projects. In addition to community-
provided literature information, PubChem generates 
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Fig. 6 Distribution of PMIDs per CID and CIDs per PMID for three types of Entrez links. Distributions of a PMIDs per CID and b CIDs per PMID are 
shown for three Entrez links between PubChem Compound and PubMed: “pccompound_pubmed”, “pccompound_pubmed_mesh”, and “pccom-
pound_pubmed_publisher”. See texts for the description of these links
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articles that share the same MeSH annotation. This auto-
mated process allows PubChem users to leverage the bio-
medical literature and its MeSH indexing for search and 
analysis purposes.
Some journals, such as Nature Chemical Biology, 
provide PubChem with information on chemicals that 
appear in their newly published articles. This enables 
PubChem to direct users to the new articles on the jour-
nal web site, even before their abstracts become available 
in PubMed. In turn, the publisher can provide their read-
ers with access to comprehensive information available 
in PubChem about the chemicals mentioned in a given 
article. This exemplifies the mutual benefit of concurrent 
publication of scientific articles in journals and associ-
ated data in public databases.
Literature information, both provided by depositors 
and derived via MeSH, can be accessed from the DocSum 
page of an Entrez search result, or from the Compound 
Summary, Substance Record, or BioAssay Record page. 
Users can also retrieve PubChem records associated 
with scientific articles, using appropriate Entrez filters. 
These tools allow PubChem users to more readily explore 
information available in literature related to PubChem 
records.
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